Literature DB >> 7449392

Long-term prognosis of pulmonary hypertension in silicosis.

R Jandová, J Widimský, L Eisler, M Navrátil.   

Abstract

Sixty patients with silicosis were examined by right heart catheterization and lung function tests during 1958-1966. In the 12-20 years follow-up the information was received of 57 patients (95%). 38 patients died (66.6%), 26 of them of the sequelae of silicosis. The death rate and the length of survival are related to mean pulmonary artery pressure, pressure gradient across pulmonary vascular bed, pulmonary vascular bed, pulmonary vascular resistance (PVR), arterial oxygen saturation (SaO2), vital capacity (VC) and forced expiratory volume (FEV). 12-year mortality in patients with pulmonary hypertension at rest was 81.3%, in contrast to 40.2% in the other patients. No patient with PVR higher than 2.55 u. survived. No patients with SaO2 lower than 89% survived 10 years. Patients with VC higher than 4000 ml at the initial examination are still living. By the method of discriminating analysis 2 main factors determining the prognosis were identified: pulmonary artery pressure and FEV 1".

Entities:  

Mesh:

Year:  1980        PMID: 7449392

Source DB:  PubMed          Journal:  Cor Vasa        ISSN: 0010-8650


  3 in total

1.  Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica.

Authors:  Igor N Zelko; Jianxin Zhu; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Respir Res       Date:  2016-11-28

2.  Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2.

Authors:  Junling Pang; Xianmei Qi; Ya Luo; Xiaona Li; Ting Shu; Baicun Li; Meiyue Song; Ying Liu; Dong Wei; Jingyu Chen; Jing Wang; Chen Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

3.  Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodeling.

Authors:  Igor N Zelko; Jianxin Zhu; Jesse Roman
Journal:  Respir Res       Date:  2018-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.